Taro Pharmaceutical Industries Ltd.
TOPICAL MONTELUKAST FOR TREATMENT OF ATOPIC DERMATITIS
Last updated:
Abstract:
A topical formulation comprising Montelukast or a pharmaceutically acceptable salt thereof, a gelling agent and water for the treatment of atopic dermatitis.
Status:
Application
Type:
Utility
Filling date:
9 Jan 2020
Issue date:
30 Jul 2020